Portfolio

Coming soon in 2024

Our team’s prior investment highlights

Tessera Therapeutics is a gene writing and editing platform with over 10x the efficiency of CRISPR.

Laronde is an endless RNA platform with novel circular RNA drugs.

IPO

4DMT is a gene therapy company with a novel AAV discovery platform.


Valo Health is an end-to-end AI drug discovery and development platform.

Insilico Medicine is an AI drug discovery platform for longevity and biotech.

Freenome is a multi-analyte AI and genomics-based liquid biopsy platform.

Life Biosciences is a longevity biotech holding developing therapies for age-related diseases.

EXO Imaging is an AI-enabled handheld ultrasound device for high quality imaging.